https://vettapharma.com/pharmaceutical-news/asco-data-show-astrazenecas-emerald-3-trial-marks-breakthrough-in-unresectable-liver-cancer/ 2026-06-04T08:33:12Z VETTAPHARMA en ASCO Data Show AstraZeneca's EMERALD-3 Trial Marks Breakthrough in Unresectable Liver Cancer 2026-06-04T10:00:00Z Blog https://vettapharma.com/pharmaceutical-news/asco-data-show-astrazenecas-camizestrant-delayed-cancer-progression-in-serena-6/ 2026-06-04T08:39:02Z VETTAPHARMA en ASCO Data Show AstraZeneca's Camizestrant Delayed Cancer Progression in SERENA-6 2026-06-04T10:00:00Z Blog https://vettapharma.com/pharmaceutical-news/sanofi-launches-action-2026-employee-share-purchase-plan/ 2026-06-04T08:52:15Z VETTAPHARMA en Sanofi Launches Action 2026: Employee Share Purchase Plan 2026-06-04T10:00:00Z Blog https://vettapharma.com/pharmaceutical-news/ucb-dapirolizumab-pegol-promising-results-in-lupus-treatment-at-eular-2026/ 2026-06-04T09:03:46Z VETTAPHARMA en UCB Dapirolizumab Pegol: Promising Results in Lupus Treatment at EULAR 2026 2026-06-04T10:00:00Z Blog https://vettapharma.com/pharmaceutical-news/fda-approves-natco-and-lupins-eribulin-injection-targeting-43-7-million-u-s-market/ 2026-06-04T09:12:24Z VETTAPHARMA en FDA Approves NATCO and Lupin's Eribulin Injection Targeting $43.7 Million U.S. Market 2026-06-04T10:00:00Z Blog https://vettapharma.com/pharmaceutical-news/mannkind-advances-nintedanib-dpi-trials-for-idiopathic-pulmonary-fibrosis/ 2026-06-03T16:26:34Z VETTAPHARMA en MannKind Advances Nintedanib DPI Trials for Idiopathic Pulmonary Fibrosis 2026-06-03T16:26:29Z Blog https://vettapharma.com/pharmaceutical-news/ema-and-ama-join-forces-to-combat-bundibugyo-ebola-outbreak/ 2026-06-03T16:23:50Z VETTAPHARMA en EMA and AMA Join Forces to Combat Bundibugyo Ebola Outbreak 2026-06-03T16:23:46Z Blog https://vettapharma.com/pharmaceutical-news/amgen-to-present-new-uplizna-and-tavneos-data-at-eular-2026/ 2026-06-03T16:23:44Z VETTAPHARMA en Amgen To Present New UPLIZNA and TAVNEOS Data at EULAR 2026 2026-06-03T16:23:39Z Blog https://vettapharma.com/pharmaceutical-news/sanofi-expands-accelrare-platform-with-biogen-to-speed-rare-disease-diagnosis/ 2026-06-03T16:23:40Z VETTAPHARMA en Sanofi Expands accelRare Platform With Biogen to Speed Rare Disease Diagnosis 2026-06-03T16:23:34Z Blog